Eli Lilly working with Humana to dispense weight-loss drugs in employer-focused initiative
Humana’s CenterWell Pharmacy will distribute Eli Lilly obesity medications under a new program targeting employers, according to a Jan. 12 news release. The pharmacy will serve those in employer plan-sponsored carve-out programs. Humana Pharmacy Segment President Bethanie Stein, PharmD, said there is untapped opportunity for “forward-thinking employer-based programs” that embrace these medications. “We’ve already seen success in […]
FDA Says to Drop Suicide Warning From GLP-1 Drug Labels
(MedPage Today) — The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a detailed review of existing data, the agency announced on Tuesday…
FDA calls on GLP-1 drugmakers to remove suicide warnings – Axios
FDA calls on GLP-1 drugmakers to remove suicide warnings Axios US FDA requests removal of suicide warnings from weight-loss drugs CNN US FDA requests removal of suicide warnings from weight-loss drug labels Reuters FDA asks popular weight loss medication makers to remove suicide risk warning kare11.com FDA Wants Suicide Warning Removed From Weight-Loss Drugs Bloomberg.com
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
The FDA asked Novo Nordisk and Eli Lilly to remove warnings about suicidal ideation or behavior from the labels of their blockbuster GLP-1 weight loss drugs. Novo’s Saxenda and Wegovy, as well as Lilly’s Zepbound …
Giving up the booze
Americans are drinking less than ever—and a growing share are teetotalers. What’s behind the trend? What do the numbers show? That the U.S. is losing its taste for the hard stuff. In a recent Gallup survey, 54% of American adults said they consumed alcohol, the lowest level since the pollster began tracking drinking behavior in […]
Increased levels of Alzheimer’s-linked protein found in some with long COVID
A study of 227 individuals who experienced neurocognitive difficulties post COVID-19 infection—such as headaches, vertigo, balance dysregulation, changes in taste/smell, and brain fog—displayed a significant increase in their blood plasma of a crucial protein called tau, which is found in nerves and especially in the brain. Excess levels of tau are linked to neurodegenerative diseases […]
New combination therapy developed for frequent form of lung cancer
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of two well-studied classes of drugs—ERBB inhibitors and Aurora kinase inhibitors—is significantly more effective against KRAS-mutated lung adenocarcinomas than existing therapies. The research, currently […]
Brain neurons process salience, valence and value separately to understand what is important—and what isn’t
The sound of a fire alarm tells us to get out quickly to not get hurt, while the sight of a gas station sign can signal a chance to refuel. In everyday life, we learn to link cues we sense with what they mean, helping us avoid danger or find what we need. But how […]
Healthcare Governance, Regulations, and Compliance – 2026 Health IT Predictions
As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! We reached out to our incredible Healthcare IT Today Community to get their insights on what will happen in the coming year, and boy, did they deliver. We, […]
GLP-1s, tariffs and health: Why food brands are reformulating
Food reformulation is a a way to adapt to challenges, such as commodity price rises, regulations or tariffs. It is also a way to embrace opportunities, such as consumer demands for healthy options and the popularity of GLP-1 weight-loss drugs. How are brands reformulating?